Categories

Six years ago, my doctor told me I had prostate cancer, and the news literally brought me to my knees. To say that I was scared at that moment is a big understatement. Nobody wants to hear the words, “You’ve got cancer,” and there are just no words to describe the devastation I felt. I…

Continue Reading

I never had a chance to meet my paternal grandfather, Eric. He was a handsome truck driver just like my Dad. In 1950, Eric had surgery to remove colon cancer at age 39. The operation went well and he was able to return to work. But the cancer returned eight years later and he lost…

Continue Reading

At Myriad, we regularly reach out to our customers in the medical and scientific communities as part of our ongoing process to understand their needs and then work with them to identify solutions to help them achieve their goals. Six or seven years ago, I embarked on one such fact-finding mission to better understand the…

Continue Reading

  To date Myriadians across the country have successfully walked, fundraised and educated colon, ovarian, and breast cancer survivors and caregivers in 7 NOCC Walks to Break the Silence on Ovarian Cancer, 1 Colon Cancer Alliance (CCA) Undy 5000 and 1 Bright Pink FabFest. For all nine events a total of $10,680 has been raised…

Continue Reading

This past September Team Myriad joined more than 500 women for Bright Pink’s annual health and wellness event, FabFest 2013. The event was co-hosted by Giuliana Rancic and Lindsey Avner, and led by Chicago’s top fitness professionals. This action-packed day pushed individuals to challenge themselves physically and inspired everyone to make lifestyle changes to proactively…

Continue Reading

Data recently presented by Myriad Genetics’ prostate cancer prognostic test Prolaris is getting healthcare professionals and patients interested in learning more about how the multi-gene prognostic test can be used to gauge prostate cancer aggressiveness. Myriad Genetics presented data at the American Society of Clinical Oncology’s annual meeting from five studies involving Prolaris, all suggesting…

Continue Reading

MELANOMA MONDAY All Year Skin cancer is one of the most common form of all cancers. Though accounting for less than 5% of all skin cancers, melanoma is the most serious form of skin cancer responsible for the majority of skin cancer attributed deaths. The American Cancer Society estimates that there will be approximately 80,000…

Continue Reading

MELANOMA MONDAY Know How to Protect Yourself Skin cancer is one of the most common form of all cancers. Though accounting for less than 5% of all skin cancers, melanoma is the most serious form of skin cancer responsible for the majority of skin cancer attributed deaths. The American Cancer Society estimates that there will…

Continue Reading

MELANOMA MONDAY Know Your Skin Skin cancer is one of the most common form of all cancers. Though accounting for less than 5% of all skin cancers, melanoma is the most serious form of skin cancer responsible for the majority of skin cancer attributed deaths. The American Cancer Society estimates that there will be approximately…

Continue Reading

Today, May 8th 2013 marks the very first World Ovarian Cancer Day. Today several organizations from around the world will join forces to raise awareness about ovarian cancer and to help educate the public about its symptoms. Approximately 11-15% of ovarian cancer cases are caused by mutations in the BRCA1 or BRCA2 genes. When someone…

Continue Reading

MELANOMA MONDAY Know The Facts Skin cancer is one of the most common form of all cancers. Though accounting for less than 5% of all skin cancers, melanoma is the most serious form of skin cancer responsible for the majority of skin cancer attributed deaths. The American Cancer Society estimates that there will be approximately…

Continue Reading

We’re in the business of saving lives.  That’s what really matters to me, and to the very bright people who work with me at Myriad.  We offer testing for patients who, based on their family history, are concerned they are at increased genetic risk for cancer.  If a woman learns from our test that she…

Continue Reading

(you can also view Jill’s video HERE) My name is Jill and I am a two-time cancer survivor—I was diagnosed with colon cancer at age 30 and endometrial cancer at age 40. My family has dealt with cancer for five generations, including three deaths from cancer. It was a mystery in my family as to…

Continue Reading

Saturday, March 9, 2013 was a chilly morning on the coast of southern California but OH WHAT A DAY! Twenty eight people and one boxer joined Team Myriad for the 2013 Undy 5000 at Mission Bay Park in San Diego to show support and raise awareness about colorectal cancer and hereditary colon cancer syndromes. Team…

Continue Reading

SALT LAKE CITY, March 5, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a study published in the Journal of Clinical Oncology demonstrated that its Prolaris test, which analyzes the expression level of 46 cell cycle progression genes, accurately predicted the elevated risk for prostate cancer recurrence in 413 men who had undergone a radical…

Continue Reading

“When I was in high school, my mom was diagnosed with breast cancer at age 42. She had a lumpectomy, chemo, and radiation. Every year since then, I would get that twinge of nervousness when she had her yearly mammogram…but the more years that went on, it would get a little easier because I had…

Continue Reading

As the shortest month of the year draws to a close, it’s important to remember that it takes longer than 28 days to prevent the impact of cancer on your life and the lives of your loved ones.  There are several life habits you can practice to improve your health and reduce your risk of…

Continue Reading

February 6, 2013 RE: COLARIS® and COLARIS AP® MYH Enhancements Myriad Genetic Laboratories, Inc. is pleased to announce enhancements to our COLARIS® and COLARIS AP® testing for Lynch syndrome and Polyposis syndromes. These important enhancements demonstrate our ongoing commitment to providing the most accurate and complete testing services possible for common hereditary cancer syndromes. COLARIS…

Continue Reading

Adam A. Ofer, MD, is a board-certified Ob/Gyn and the Director of Gynecology at the Norwalk Hospital in Connecticut.  His focus is in urogynecology and minimally-invasive surgery, including da Vinci surgery (a minimally invasive alternative to both open surgery and laparoscopy).    We are very lucky to have Dr. Ofer as one of our healthcare…

Continue Reading

There are limited recommendations on this topic.1 The following summarizes the literature, however, a clinician’s judgment will also be based on the patient’s age, co-morbidities and individual circumstances. Management after risk-reducing mastectomy Prophylactic mastectomy reduces the risk of breast cancer in BRCA carriers by about 90%,2

Continue Reading

The holidays are known as a time for giving and Myriad proudly helped bring that giving spirit to the Cancer Wellness House’s annual holiday party.  The Cancer Wellness House has been serving Salt Lake City and its surrounding areas since 1997 with the goal of supporting and uniting people and families dealing with cancer through…

Continue Reading

Dreaming of a White Christmas?  Better get out the sunscreen and shades! Being smart about the UV rating and your exposure during the winter is almost more important than in the summer (especially in the high altitude snow states).  Snow reflects 80% of the dangerous UV rays compared with 25% from sea form and 15%…

Continue Reading

This past week Myriad Genetic Laboratories had the opportunity to present 2 posters at the Society for Urologic Oncologists that was held in Bethesda, MD.  The first poster, DEVELOPMENT AND VALIDATION OF A MULTIVARIATE MODEL COMBINING CELL CYCLE PROGRESSION SCORE WITH CAPRA TO PREDICT PROSTATE CANCER MORTALITY IN A CONSERVATIVELY MANAGED COHORT was presented by…

Continue Reading

SALT LAKE CITY, Nov. 28, 2012 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled “CCP Score Significantly Predicts PSA Failure After EBRT,” was presented on Wednesday, November 28th, 2012 at the Annual Meeting of the Society of Urological Oncology in Bethesda, Maryland. The study demonstrates that the Prolaris® test, which measures cell cycle progression (CCP) genes, significantly predicts PSA…

Continue Reading

It’s that time of year again! We want to remind you that during all of these family holiday gatherings it is a great time to talk to your family members about your family’s medical history.  Knowing this information about your family is very important for making informed decisions about your own healthcare.  It is important…

Continue Reading

The Great Prostate Cancer Challenge (GPCC) is the premier men’s health race and event series in America.  It is an exciting community activity that brings together athletes, cancer survivors, healthcare professionals, caretakers, family members and friends. The mission of GPCC is to raise awareness of Prostate Cancer, raise funds for Prostate Cancer research and provide…

Continue Reading

In the last weeks, Myriad Genetics has been conducting alumni speaker trainings for its front-line healthcare professional and mid-level providers. These providers have previously worked with Myriad to speak with their peers in a variety of settings, from presentations to a large number of providers at sponsored events,  at medical society meetings and meeting one…

Continue Reading

Myriad is excited to announce the launch of the online Hereditary Cancer Quiz. This quiz was designed for the general public as an easy to use, online quiz that can help determine if you are a candidate for hereditary cancer testing. The intent of the quiz is to not only to see if you are…

Continue Reading

Know Your Skin Hereditary melanoma is just one risk factor for this rare but deadly form of skin cancer.  Knowing your skin and checking it monthly is the first step in preventing melanoma.   Make the 1st day of the month an easy day to remember to check your skin for the signs of skin cancer. …

Continue Reading

If you notice more people walking around with mustaches this month don’t be surprised! In the past 9 years the “movember” movement has grown from 30 participants originating in Melbourne, Australia to over 1.9 million participants worldwide!  The term “movember” combines the words “ Mustache” and “November” and the goal of the movement is to raise awareness for…

Continue Reading

William J. Harb, MD, FACS, FASCRS, is a board-certified colorectal surgeon, specializing in the treatment of diseases of the colon and rectum…and he is a speaker for Myriad! Dr. Harb’s clinical interests include treating inherited colon and rectal cancers. Through his dedication and national recognition with hereditary colorectal cancer, genetic testing has become an integral…

Continue Reading

This fall Myriad participated in eleven National Ovarian Cancer Coalition Walks to Break the Silence on Ovarian Cancer with just one more walk to go in San Antonio, Texas this November.  Between team building, fundraising, information giving, walking and just plain having fun, Myriad was able to raise awareness about both hereditary breast and ovarian…

Continue Reading

On Sunday, October 21, 2012 Dr. Matthew McKinley spoke about the importance of hereditary colorectal cancer at the American College of Gastroenterology’s Annual Scientific Meeting in Las Vegas, Nevada.  Myriad employees were on-site after the presentation and took questions about how testing for hereditary colon cancer plays a key role in the treatment of those…

Continue Reading

A group of Myriad employees attended the Annual Huntsman Cancer Foundation Gala and Survivorship Celebration last Thursday evening at the Grand America Hotel in downtown Salt Lake City. Myriad has been a supporter of the event for several years, and both Huntsman and Myriad share a similar vision for future advancements in cancer technologies and…

Continue Reading

Myriad Genetics is being featured in the November edition of Forbes Magazine! Read the article online HERE and grab a copy when it hits newsstands on November 5th  — Natalie VavrasekInteractive Associate Product Manager

Continue Reading

On Friday, October 19th representatives from Myriad had the distinct pleasure of attending the Red Ball in Manhattan, New York. The Red Ball is an evening of fun, dancing and shopping put on by The Young Leadership Council of the Cancer Support Community (CSC), an organization whose mission is “to ensure that all people impacted…

Continue Reading

On September 28th, 2012 Myriad partnered with Living Beyond Breast Cancer (LBBC) to educate breast cancer survivors at the Annual LBBC Conference about Hereditary Breast and Ovarian Cancer syndrome. In a very casual setting atop the 33rd floor of the Loews Hotel in downtown Philadelphia, Cynthia Kimball – patient advocate and breast cancer survivor and Jill…

Continue Reading

This past Saturday, October 13th, 2012, Myriad employees took to the pavement in the annual American Cancer Society’s Making Strides Against Breast Cancer walk in Salt Lake City, UT. Team Myriad, comprised of several employees, friends and vendors, raised nearly $8,000! Myriad Genetics, Inc. matched the donation bringing the grand total to $15,392 which made Team…

Continue Reading

We would like to take a few Mondays each month to introduce you to some of our shining star employees here at Myriad Genetics. These employees exemplify what it means to be a Myridian. Their efforts at the office and in the community are what Myriad stands for! Our first spotlight is on Colleen Walch, a Patient…

Continue Reading

Leslie had everything planned for her upcoming Thanksgiving feast. Her Christmas shopping lists were in order, and she was ready to host the rehearsal party for her son’s December 28th wedding. What she wasn’t ready for, was the unexpected arrival of cancer. In the 1970s I lost both of my parents to cancer. They were…

Continue Reading

Today was an inspirational day here at Myriad.  We had two amazing speakers on hand to discuss their organizations, David Barley, CEO of National Ovarian Cancer Coalition, (NOCC) as well as a representative from Bright Pink.  It was very powerful to hear about all the amazing advocacy work each organization is doing.  (Pictured Above: David Barley,…

Continue Reading

September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor refers to an individual who carries a strong predisposition to cancer but has not developed cancer. These individuals proactively sought out knowledge to determine if they inherited a gene mutation by having genetic testing…

Continue Reading

More than 20,000 women are diagnosed with ovarian cancer each year, and approximately 15,000 women die from the disease each year. Since there is no early detection test, most cases are diagnosed in later stages when prognosis is poor. When ovarian cancer is found early at a localized stage, prognosis is good for the majority…

Continue Reading